CUSIP 98420X202COM NEWXFORQ4 2025
23 filings · latest Mar 6, 2026
Largest reported positions · latest quarter
| # | Fund | Shares | Value |
|---|---|---|---|
| 1 | Empery Asset Management, LP | 8.95M | $35.80M |
| 2 | Fmr LLC | 8.50M | $34.00M |
| 3 | Morgan Stanley | 8.21M | $32.83M |
| 4 | Bain Capital Life Sciences Investors, LLC | 7.97M | $31.87M |
| 5 | Perceptive Advisors LLC | 6.31M | $25.26M |
| 6 | Saturn V Capital Management LP | 5.80M | $23.20M |
| 7 | Deep Track Capital, LP | 5.01M | $20.05M |
| 8 | Kalehua Capital Management LLC | 3.72M | $14.89M |
| 9 |
| 4 | Feb 17, 2026 | Saturn V Capital Management LP | 13G | 7.4% | 6.43M | SEC |
| 5 | Feb 17, 2026 | Biotechnology Value Fund L P | 13G/A | 3.9% | 3.41M | SEC |
| 6 | Feb 13, 2026 | Nantahala Capital Management, LLC | 13G/A | 2.8% | 2.45M | SEC |
| 7 | Feb 12, 2026 | Morgan Stanley | 13G | 9.4% | 8.20M | SEC |
| 8 | Feb 5, 2026 | Fmr LLC | 13G/A | 9.7% | 8.50M | SEC |
| 9 | Jan 15, 2026 | Empery Asset Management, LP | 13G/A | 10.0% | 9.04M | SEC |
| 10 | Nov 14, 2025 | Nantahala Capital Management, LLC | 13G | 10.0% | 2.24M | SEC |
See the full Schedule 13D/13G history for X4 Pharmaceuticals Inc.
Unlock full history| Vanguard Group Inc |
| 3.42M |
| $13.69M |
| 10 | Braidwell LP | 3.37M | $13.48M |